ESR1 and breast cancer: A downregulation of miR-222 increases ERα and p27 expressions at the mRNA and protein levels and restores the sensitivity of cells to TAM; furthermore, exosomal miR-222 may enhance the resistance to TAM by upregulating ERα and p27 in ER-BC cells [107].